A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis
Status:
Recruiting
Trial end date:
2023-09-23
Target enrollment:
Participant gender:
Summary
This is a 2 year clinical study to compare 5-grass mix SLIT-drops with placebo in relieving
grass pollen-induced rhinoconjunctivitis symptoms and in use of symptom-relieving medication
during the second grass pollen season (peak grass pollen season, PGPS)
The study will collect health-related quality of life data in the groups treated with 5-grass
mix SLIT-drops or with placebo during the first and second PGPS.
The trial medication used is already approved to treat allergic rhinitis caused by grass
pollen in adults in several countries.